Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

被引:43
|
作者
Benhamou, P. Y. [1 ]
Milliat-Guittard, L. [2 ,10 ]
Wojtusciszyn, A. [3 ]
Kessler, L. [4 ,11 ]
Toso, C. [5 ]
Baertschiger, R. [5 ]
Debaty, I.
Badet, L. [9 ]
Penfornis, A. [6 ]
Thivolet, C. [7 ,10 ,12 ]
Renard, E. [3 ]
Bayle, F. [8 ]
Morel, P. [5 ]
Morelon, E. [9 ,10 ]
Colin, C. [2 ,10 ]
Berney, T. [5 ]
机构
[1] CHU Grenoble, Dept Endocrinol, Clin Endocrinol, F-38043 Grenoble, France
[2] Univ Lyon, EA Sante Individu Soc 4129, Lyon, France
[3] Ctr Hosp Montpellier, Serv Endocrinol, Montpellier, France
[4] Univ Strasbourg, Fac Med, Strasbourg, France
[5] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland
[6] Hop Jean Minjoz, Serv Endocrinol Metab & Diabet Nutr, F-25030 Besancon, France
[7] Univ Lyon, Fac Laennec, INSERM, U449, Lyon, France
[8] CHU Grenoble, Serv Nephrol, F-38043 Grenoble, France
[9] Hosp Civiles Lyon, Serv Nephrol Med Transplantat & Immunol, Clin Pavillon P, Lyon, France
[10] Univ Lyon 1, F-69365 Lyon, France
[11] Hop Univ Strasbourg, Serv Endocrinol Diabet & Malad Metabol, Strasbourg, France
[12] Hosp Civils Lyon, Serv Endocrinol Diabete Nutr Pavillon X, Lyon, France
关键词
health-related quality of life; pancreatic islet transplantation; Type 1 diabetes mellitus;
D O I
10.1111/j.1464-5491.2009.02731.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rigorous assessment of health-related quality of life (HRQL) is mandatory to establish the benefits of islet transplantation. The 36-Item Short Form Health Survey (SF-36) and the Diabetes Quality of Life (DQOL) scales were completed by patients included in an Islet Transplantation Alone (ITA) trial (n = 10) and an Islet After Kidney (IAK) trial (n = 10). The two populations differed by HRQL scores at baseline, with poorer scores in ITA patients. SF-36 scores for physical limitations, bodily pain, general health perception, social functioning, and health transition improved significantly in ITA patients 6 and 12 months post transplantation. The DQOL global score was significantly improved at 6 months and remained so at 12 months, because of a significant improvement in the dimensions of satisfaction and impact of diabetes. No improvement was observed in the IAK patients. HRQL assessment may help in the selection of candidates with brittle diabetes for islet transplantation.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 50 条
  • [1] Assessment of the metabolic and quality of life after pancreatic islet transplantation in diabetic patients with type 1 renal transplantation: results of the group Gragil
    Wojtusciszyn, A.
    Brault, C.
    Niklauss, N.
    Badet, L.
    Renard, E.
    Colin, C.
    Thivolet, C.
    Frimat, L.
    Penfornis, A.
    Berney, T.
    Kessler, L.
    Benhamou, P. Y.
    DIABETES & METABOLISM, 2009, 35 : A10 - A10
  • [2] Expectations and strategies regarding islet transplantation: Metabolic data from the GRAGIL 2 trial
    Badet, Lionel
    Benhamou, Pierre Y.
    Wojtusciszyn, Anne
    Baertschiger, Reto
    Milliat-Guittard, Laure
    Kessler, Laurence
    Penfornis, Alfred
    Thivolet, Charles
    Renard, Eric
    Bosco, Dominico
    Morel, Philippe
    Morelon, Emmanuel
    Bayle, Francois
    Colin, Cyrille
    Berney, Thierry
    TRANSPLANTATION, 2007, 84 (01) : 89 - 96
  • [3] Improved metabolic control and quality of life in 10 patients with type 1 diabetes following islet after kidney transplantation: results of the GRAGIL 1 trial
    Wojtusciszyn, A.
    Brault, C.
    Guittard-Millat, L.
    Niklauss, N.
    Badet, L.
    Demuylder, S.
    Penfornis, A.
    Thivolet, C.
    Colin, C.
    Renard, E.
    Frimat, L.
    Bayle, F.
    Kessler, L.
    Berney, T.
    Benhamou, P.
    DIABETOLOGIA, 2009, 52 : S189 - S189
  • [4] Quality of life after islet transplantation
    Poggioli, R
    Faradji, RN
    Ponte, G
    Betancourt, A
    Messinger, S
    Baidal, DA
    Froud, T
    Ricordi, C
    Alejandro, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (02) : 371 - 378
  • [5] Quality of life after islet transplantation
    Poggioli, R
    Ponte, G
    Baidal, DA
    Cure, P
    Pileggi, A
    Messinger, S
    Betancourt, A
    Froud, T
    Faradji, RN
    Ricordi, C
    Alejandro, R
    DIABETES, 2005, 54 : A86 - A86
  • [6] Impact of Anti-Insulin Antibodies on Islet Transplantation Outcome: Data From the GRAGIL Network
    Lablanche, Sandrine
    Borot, Sophie
    Thaunat, Olivier
    Bayle, Francois
    Badet, Lionel
    Morelon, Emmanuel
    Thivolet, Charles
    Wojtusciszyn, Anne
    Frimat, Luc
    Kessler, Laurence
    Penfornis, Alfred
    Brault, Coralie
    Colin, Cyrille
    Bosco, Domenico
    Berney, Thierry
    Benhamou, Pierre Y.
    TRANSPLANTATION, 2014, 98 (04) : 475 - 482
  • [7] Impact of the Number of Infusions on 2-Year Results of Islet-After-Kidney Transplantation in the GRAGIL Network
    Borot, Sophie
    Niclauss, Nadja
    Wojtusciszyn, Anne
    Brault, Coralie
    Demuylder-Mischler, Sandrine
    Mueller, Yannick
    Giovannoni, Laurianne
    Parnaud, Geraldine
    Meier, Raphael
    Badet, Lionel
    Bayle, Francois
    Frimat, Luc
    Kessler, Laurence
    Morelon, Emmanuel
    Penfornis, Alfred
    Thivolet, Charles
    Toso, Christian
    Morel, Philippe
    Bosco, Domenico
    Colin, Cyrille
    Benhamou, Pierre-Yves
    Berney, Thierry
    TRANSPLANTATION, 2011, 92 (09) : 1031 - 1038
  • [8] Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network
    Lablanche, Sandrine
    Borot, Sophie
    Wojtusciszyn, Anne
    Skaare, Kristina
    Penfornis, Alfred
    Malvezzi, Paolo
    Badet, Lionel
    Thivolet, Charles
    Morelon, Emmanuel
    Buron, Fanny
    Renard, Eric
    Tauveron, Igor
    Villard, Oriane
    Munch, Marion
    Sommacal, Salome
    Clouaire, Lea
    Jacquet, Morgane
    Gonsaud, Laura
    Camillo-Brault, Coralie
    Colin, Cyrille
    Bosson, Jean-Luc
    Bosco, Domenico
    Berney, Thierry
    Kessler, Laurence
    Benhamou, Pierre-Yves
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (11) : 3725 - 3733
  • [9] Improved long-term quality of life after islet transplantation
    Tharavanij, Thipaporn
    Betancourt, Arthur
    Messinger, Shari
    Cure, Pablo
    Baidal, David A.
    Leitao, Cristiane B.
    Bernetti, Karina
    Froud, Tatiana
    Ricordi, Camillo
    Alejandro, Rodolfo
    DIABETES, 2008, 57 : A110 - A110
  • [10] THE FREQUENCY AND QUALITY OF REPORTING OF QUALITY OF LIFE DATA IN TRIALS OF IMMUNOSUPPRESSIVE AGENTS IN KIDNEY TRANSPLANTATION
    Howell, M.
    Wong, G.
    Tong, A.
    Turner, R.
    Craig, J.
    Howard, K.
    NEPHROLOGY, 2012, 17 : 84 - 84